Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-26 @ 3:03 AM
Study NCT ID:
NCT01492920
Status:
WITHDRAWN
Last Update Posted:
2014-12-31
First Post:
2011-12-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
Sponsor:
Gynecologic Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2015-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2011-12-14
First Submit QC Date:
None
Study First Post Date:
2011-12-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-12-29
Last Update Post Date:
2014-12-31
Last Update Post Date Type:
ESTIMATED